Nuvectis Pharma, Inc. NVCT Business Segments — Segment Reporting Other Item Amount

Similar metrics at other companies

BVDevelopment Services — Segment Reporting Other Item Amount

$27.7M+7.4%

IRONOther Segment Items — Segment Reporting Other Item Amount

$6.02M+2.7%

LGNDDevelopment and Licensing of Biopharmaceutical Assets — Segment Reporting, Other Segment Item, Amount

$51.16M-29.0%

WORConsumer Products — Segment Reporting Other Item Amount

-$25K-308%

VSATCommunication Services — Segment Reporting Other Item Amount

$527.12M+0.9%

RLGTSegment Reporting, Other Segment Item, Amount

-$271K-113%

Questions, answered.

What is Nuvectis Pharma, Inc.'s business segments — segment reporting other item amount?

Nuvectis Pharma, Inc. (NVCT) reported business segments — segment reporting other item amount of -$210K in Q1 2026.

How has Nuvectis Pharma, Inc.'s business segments — segment reporting other item amount changed year-over-year?

Nuvectis Pharma, Inc.'s business segments — segment reporting other item amount increased by 11.0% year-over-year, from -$236K to -$210K.

What does business segments — segment reporting other item amount mean?

Residual financial items or non-recurring adjustments allocated to the clinical development segment that do not fit into standard expense categories. Monitoring this helps identify unusual or one-time impacts on segment performance.